China Money Network
Login
Join

Hillhouse-Backed Biotech Firm I-Mab Eyes $100M In US IPO

  • October 30, 2019 — 17:04 CST

This Data Is Locked!

This area is available only to Subscribers.

I-Mab Biopharma, a Chinese-clinical stage biopharmaceutical company, has filed for an up to US$100 million IPO of American Depository Shares (ADS) on the Nasdaq on... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: